Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Business, Policy & Funding » Regulatory News & FDA Approvals » Antegenes Receives CE Marks for Cancer, Melanoma Polygenic Risk Score Tests

Antegenes Receives CE Marks for Cancer, Melanoma Polygenic Risk Score Tests

Aug 19, 2020
|
staff reporter

NEW YORK ─ Antegenes said on Wednesday that it has received CE marking for four polygenic risk score (PRS) tests ─ AnteBC for breast cancer, AntePC for prostate cancer, AnteCRC for colorectal cancer, and AnteMEL for melanoma.

The Estonia-based biotech company has launched the tests for use in the European Union and other countries that accept the designation.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Plans Out

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

CovidNudge Numbers

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

Science Papers Propose Group to Discuss Genome-Editing Tools, Markers of Diabetes Drug Response, More

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

Not Counting These

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.

Oct
09
Featured Webinar

Navigating the FDA's EUA Process for Diagnostics in the Present and Future: A Stakeholder Panel Discussion

Sponsored by
PerkinElmer

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.

What's Popular?

In Regulatory News & FDA Approvals

  1. Roche Gets FDA Emergency Use Authorization for Rapid Coronavirus, Flu Test

  2. DiaSorin Receives CE Mark to Use Saliva Samples With COVID-19 Test

  3. FDA Grants Emergency Use Authorization to Coronavirus Tests From Visby Medical, SNIBE

  4. Eurobio Gets CE Mark for Multiplexed SARS-CoV-2, Influenza A/B, RSV Test

  5. GenMark Diagnostics Receives CE Mark for Respiratory Panel Including SARS-CoV-2, Flu

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.